Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses

Influenza is known as a respiratory infectious disease. Breastfeeding allows for frequent microbial exchange between infant and mother. Although infants, pregnant women and breastfeeding mothers are more susceptible to severe respiratory disease following influenza virus infection, the mechanisms of disease severity in infants and mothers is poorly understood. We were interested in understanding the immune responses, pathogenicity, and transmission dynamics in the infant-mother system. With this aim we developed an infant-mother ferret influenza model. Influenza infection in infants led to virus transmission to mothers causing severe disease and mortality. Unexpectedly, influenza-infected infant ferrets transmitted the virus to mother mammary glands leading to live influenza virus in expressed breast milk. Gene regulation analysis in the mammary gland showed reduction of milk production genes such as Prolactin and increased genes involved with breast shutdown. Genes associated with cancer development were significantly increased including JUN, FOS and BRCA2. We found human breast cells were able to be infected with the influenza virus suggesting the importance of our results to human health. Our data suggests influenza transmission can occur through the mammary glands initiating immunological and pathological events contributing to influenza disease severity impacting infant and maternal health.

Published in the journal: . PLoS Pathog 11(10): e32767. doi:10.1371/journal.ppat.1005173
Category: Research Article
doi: 10.1371/journal.ppat.1005173


Influenza is known as a respiratory infectious disease. Breastfeeding allows for frequent microbial exchange between infant and mother. Although infants, pregnant women and breastfeeding mothers are more susceptible to severe respiratory disease following influenza virus infection, the mechanisms of disease severity in infants and mothers is poorly understood. We were interested in understanding the immune responses, pathogenicity, and transmission dynamics in the infant-mother system. With this aim we developed an infant-mother ferret influenza model. Influenza infection in infants led to virus transmission to mothers causing severe disease and mortality. Unexpectedly, influenza-infected infant ferrets transmitted the virus to mother mammary glands leading to live influenza virus in expressed breast milk. Gene regulation analysis in the mammary gland showed reduction of milk production genes such as Prolactin and increased genes involved with breast shutdown. Genes associated with cancer development were significantly increased including JUN, FOS and BRCA2. We found human breast cells were able to be infected with the influenza virus suggesting the importance of our results to human health. Our data suggests influenza transmission can occur through the mammary glands initiating immunological and pathological events contributing to influenza disease severity impacting infant and maternal health.


The influenza A RNA virus (Orthomyxoviridae) is a significant threat to human health and the global economy by causing morbidity and mortality through frequent epidemics and sporadic pandemics [1]. Seasonal influenza viruses such as seasonal H1N1 and H3N2 infect the cells lining the upper respiratory tract. These viruses typically cause mild clinical symptoms including rhinorrhea, fever, and myalgia [2]. Unlike seasonal influenza, highly pathogenic viruses such as avian H5N1 are able to infect organs outside the upper respiratory tract such as the lower lungs, intestines, and brain, causing a more severe illness [3]. The localization of influenza virus infection is largely influenced by the distribution of the virus cellular receptors where the α2,6-linked sialic acid receptor is predominantly expressed in the upper respiratory tract and α2,3-linked sialic acid receptors in the lower [4]. In 2009, a novel variant pandemic H1N1 influenza A (2009 H1N1) virus emerged from Mexico that targets both the upper and lower respiratory system [4]. During the 2009 H1N1 pandemic, infants, nursing-mothers, and pregnant women were considered to be at high risk of developing severe disease [57] and viral or bacterial pneumonia [8]. Pediatric and pregnant/postpartum mother mortalities were sharply increased in the 2009–2010 influenza season compared to previous seasons [9,10]. Importantly, the underlying mechanisms leading to severe disease in mothers and infants have not been elucidated, suggesting the need for an animal model.

The mother-infant dyad represents a unique relationship where the infant and mother are often considered to function as a single unit. Through breastfeeding, mothers provide nutrients, beneficial bacteria, and immune protection to the infant by transfer of cells, antibodies, proteins, and sugars through breast milk [11,12]. The consumption of breast milk has a central role establishing infant health and disease susceptibility by influencing the infant gastrointestinal and immune systems [13,14]. The maternal breast is a highly structured organ and an area of frequent traffic between infant and mother. Fluid exchange also occurs from infant to mother during breastfeeding as liquid can infiltrate the mammary gland through retrograde flux of the nipple [15]. It is currently thought that maternal plasma cells producing antibodies for breast milk delivery are a consequence of cellular migration from the maternal gut to the breast without a host-pathogen interaction occurring within the mammary gland [16]. Although most infants worldwide are breastfed, little is known regarding pathogen transmission between nursing-mothers and infants, breast susceptibility to pathogens, or the local immune response within the breast due to lack of a translatable research model [5].

Breast disease is a significant problem worldwide. The postpartum and lactation phase in breast metamorphosis has been associated with increased breast cancer incidence. While breastfeeding has been shown to protect against long-term breast cancer development, postpregnancy breast cancer is hypothesized to be a consequence of breast remodeling and involution associated with lactation [17,18]. Infectious breast tumor etiologies have been hypothesized as nucleic acids from viruses, such as human papilloma virus (HPV) and Epstein-Barr virus (EBV), have been recovered from within breast tumors [1922]. These viruses express oncoproteins that inactivate the host’s basic cellular activity by blocking tumor repressor proteins or promote cellular transformation [23]. Furthermore, these viruses may have a significant latency period allowing long periods of viral presence without clearance.

Although infants and mothers are highly susceptible to the influenza virus [2427], little is known regarding mother-infant transmission and susceptibility of breast tissue. We developed a ferret model of influenza transmission in the mother-infant dyad (infant-to-mother ferret influenza transmission model) with the aim of investigating virus transmission and immune consequences during influenza infection in this highly susceptible population. Ferrets are considered to be the most appropriate animal model for human influenza pathogenesis, vaccine optimization, and antiviral development [28,29]. Ferrets are also used to investigate transmissibility of the influenza virus due to the similarity of the ferret and human respiratory biology [2931]. Previously, we developed both “young” and “aged” ferret models of influenza pathogenesis due to shared characteristics of development and aging between ferrets and humans [32,33]. Building on these studies, we developed a novel infant-mother ferret influenza model utilizing nursing-mother ferrets and their 4-week-old feeding-infants (infant-mother ferret influenza transmission model) to investigate the host-pathogen interactions of influenza virus infection in the mother-infant dyad. Our investigation showed established virus infection within the mammary gland and viral shedding in breast milk suggesting a novel mechanism of influenza virus transmission.


Severe morbidity, mortality, and respiratory disease following influenza transmission from infant to mother

To investigate influenza infection in the mother-infant dyad, we intranasally inoculated 4-week-old infant ferrets with the 2009 H1N1 virus, A/California/07/2009 (Cal/07), at 105 EID50. Infants were housed with nursing-mothers before and after inoculation. Nasal washes (NW), temperature, weight, clinical assessment, and survival were collected daily as shown in the design schematic (Fig 1A). Necropsies were performed at Day 3, 4, 7, and 14 post-inoculation or if an animal was removed from the study (reached weight cut-off or had succumbed to illness). Inoculated infant ferrets developed illness leading to mortality starting with a high fever at 104% of baseline temperature (p<0.05) Day 2 post-infant-inoculation. Infants then developed hypothermia (Day 6) (Fig 1B). All infants reached weight cut-off (lost 20% of original weight; p<0.05) or died by Day 8 post-infant-inoculation (Fig 1C and 1D). Four days post-infant-inoculation, nursing-mother ferrets also developed influenza-like symptoms including increased body temperature (103% of baseline). Mother weights significantly decreased by 13% Day 4 post-infant-inoculation (Fig 1C). Weight did not recover by study end and one mother reached cut-off (Fig 1D). The weight and temperature of the mothers of mock inoculated control infants are presented in S1 Table which showed mothers did not develop symptoms post-mock-inoculation of infant ferrets.

Intranasal 2009 H1N1 infection in infant ferrets leads to severe disease and mortality in both mother and infant ferrets.
Fig. 1. Intranasal 2009 H1N1 infection in infant ferrets leads to severe disease and mortality in both mother and infant ferrets.
Schematic of experimental design for mother-infant dyad inoculations (A). Infants were intranasally inoculated with the A/Cal strain of 2009 H1N1 influenza (105 EID50) and housed with their nursing-mothers. Temperature (B) and weight (C) were recorded for 14 days post-infant-inoculation. Control mock inoculated infants (grey lines) were used to assess natural fluctuations in growing infants. Survival of mothers and infants was determined over 14 days (D). Results show the mean or are representative of 3 independent litter inoculations/infections (3 mother ferrets and 19 infant ferrets) and 3 litter mock inoculations (3 mother ferrets and 11 infant ferrets). * indicates a p-value less than 0.05 determined by ANOVA comparing 2009 H1N1 inoculated/infected to mock controls. Error bars indicate +/- SE.

As the mothers of inoculated infants began to display clinical signs of influenza including temperature increases, weight loss, and mortality, we went on to analyze the upper and lower respiratory tracts of the infants and their mothers to determine virus transmission and pathogenesis. Viral burden in infant NW was first detected Day 1 post-infant-inoculation (Fig 2A). The NW of nursing-mothers were positive for influenza virus Day 3 post-infant-inoculation. Viral titers remained high in mother NW Day 6–7 (Fig 2A) at more than 6 TCID50/ml (Log10). Residual virus persisted in the mothers’ NW by Day 10 (S1A Fig). Virus transmission between adult ferrets pair-housed (S1C Fig) were used as a comparison of transmission dynamics between infants and mother ferrets. For this control, one adult was intranasally inoculated under similar circumstances as the infant-mother inoculations and NW were collected for viral load assessment. Naïve cage mates of inoculated adult ferrets began shedding virus in NW Day 3 post-inoculation. These results showed that the influenza virus was able to be transmitted from direct intranasally inoculated infant ferrets to the upper respiratory tracts of their nursing-mothers on a similar time scale as that of adult ferrets.

Transmission of H1N1 influenza from infants to mother ferrets causes upper and lower respiratory tract infection with significant pathology.
Fig. 2. Transmission of H1N1 influenza from infants to mother ferrets causes upper and lower respiratory tract infection with significant pathology.
Inoculated infants (A/Cal H1N1 influenza (105 EID50)) were housed with their nursing-mothers. Nasal washes were collected daily from infants and mothers. Live viral loads were determined by MDCK titration assay in nasal wash (NW) (A) and mother trachea and mother lungs at specific time points (B). Lungs were harvested on Day 3/4 and 7 post-infant-inoculation for hematoxylin & eosin (H&E) histopathological assessment from nursing-mothers of inoculated infants and directly inoculated adult ferrets as control (C). Green arrows denote dense cell accumulation; black arrows denote diffuse immune cell infiltration. Black arrows not included on Day 7 adult tissue due to widespread infiltration. High resolution scans were performed using an Aperio ScanScope XT, Leica Biosystems, Nußloch, Germany. The left and central columns of mother images represent a low and high magnification of each lung scan. The scale bars indicate the relative 100 μm. Results of A are representative of 3 independent litter inoculations where nasal washes were collected from 3 mothers and 9 infants (3 per litter) daily. Results of B and C are from 6 independent litter inoculations of serial tissue collections (3 collected Day 3/4 and 3 collected Day 7). Error bars indicate +/- SD. Mock: mother ferrets nursing mock-inoculated 4-week-old infant ferrets. Results show the mean or are representative of independent litter inoculations/infections.

We next determined if transmission of the virus from infants to mother led to lower respiratory tract infection. Examination of viral titers in the lower respiratory tract of the mothers found virus levels above 6 TCID50/ml (Log10) in both the trachea and lungs post-infant-inoculation in 2 out of 3 mothers investigated (Day 4 and 7 post-infant-inoculation) (Fig 2B). H&E (hematoxylin & eosin) staining of mother lungs revealed delayed, airway-localized inflammation (Fig 2C). Day 3/4 post-infant-inoculation, mother lungs showed areas of minimal infiltrating leukocytes (black arrows: diffuse areas; green arrows: dense infiltration) (Fig 2C). Increased leukocyte infiltration was observed Day 7 post-infant-inoculation where sites of inflammation were dense in mononuclear cells with lymphocyte-like morphology. Infected mother lungs were compared to the lungs of adult male ferrets directly inoculated with Cal/07 through the intranasal route (Fig 2C, right column). The lungs collected from mothers of mock inoculated infants were similar in architecture to that of mock inoculated adult male ferrets. The adult lungs collected Day 3/4 post-direct-inoculation had markedly more leukocyte infiltrates compared to the mother lungs at Day 3/4 post-infant-inoculation (Fig 2C). Taken together with the above data, these findings indicated that 2009 H1N1 transmission from infant to mother led to severe respiratory disease with upper and lower respiratory tract infection and accompanying lung pathology but on a delayed time course compared to direct adult infections.

Influenza virus transmission also occurs mother to infant

To determine if influenza infected nursing-mother ferrets could transmit the virus to their feeding-infants, we reversed the inoculation/infection design as shown in the schematic (Fig 3A). We intranasally inoculated nursing-mothers with Cal/07 at 105 EID50 and observed clinical symptoms as well as determined respiratory viral load and pathogenesis. Following inoculation, nursing-mother ferrets developed a biphasic fever which spiked at 104% (baseline temperature) (Fig 3B) Day 3 post-mother-inoculation. Weight loss was observed in the inoculated mothers which reached nadir on Day 7 post-mother-inoculation at 89% of original weight (p<0.05) (Fig 3C). Although mother mortality did not occur, the infants of inoculated mothers lost weight, had increased temperature, and all died or reached cut-off by Day 11 post-mother-inoculation (Fig 3D). The weight of infants of inoculated nursing-mothers began to decline on Day 3 (Fig 3C). Although infants did not have a significant increase in temperature they did become hypothermic as they reached mortality (Fig 3B). Virus was detected in mother NW Day 1 post-mother-inoculation (peak Day 2 at 6 TCID50/ml (Log10)) and infant viral shedding began Day 3 (Fig 3E). Live influenza virus was detected in the lungs of infants reaching weight cut-off or succumbing to illness between Day 5 and Day 8 post-mother-inoculation (3–8 TCID50 (Log10)) (Fig 3F). Significant pathology was also detected in lungs of infants feeding from 2009 H1N1 inoculated nursing-mothers Day 7 post-mother-inoculation. The lungs were characterized by areas of dense leukocyte infiltration and alveoli destruction (Fig 4). In summary, these data indicate that influenza transmission was also possible from mother to feeding-infants causing upper and lower respiratory tract infection and respiratory tract disease.

Intranasal 2009 H1N1 infection in mother ferrets leads to severe disease and virus transmission to breastfeeding infants.
Fig. 3. Intranasal 2009 H1N1 infection in mother ferrets leads to severe disease and virus transmission to breastfeeding infants.
Schematic of nursing-mothers intranasally inoculated with the Cal/07 strain of 2009 H1N1 influenza (105 EID50) and housed with their feeding infants (A). Temperature (B) and weights (C) were recorded daily for mothers and infants post-inoculation. Grey lines indicate mock inoculated mothers. Survival of mothers and infants post-mother-inoculation (D). Live viral loads were quantified by MDCK titration of nasal wash (NW) (E) and infant lung (F) homogenates collected throughout the infection course (infants that had reached cut-off or succumbed to illness). * indicates a p-value less than 0.05 determined by ANOVA comparing H1N1 inoculated to mock controls. Error bars indicate +/- SD. Data was collected from three independent litter inoculations/infections (3 inoculated/infected mothers, 16 infants, and 3 mock inoculated/infected mothers) and results show the mean or are a representative of the inoculations/infections.

2009 H1N1 transmission from mothers to infants results in severe lower respiratory tract pathology.
Fig. 4. 2009 H1N1 transmission from mothers to infants results in severe lower respiratory tract pathology.
Harvested lungs from control infants and infants of inoculated nursing-mothers were processed for histopathological assessment. Tissue morphology was assessed by hematoxylin & eosin staining. Data was collected from three independent litter inoculations/infections (3 inoculated/infected mothers, 16 infants, and 3 mock inoculated/infected mothers) and results are a representative of the inoculations/infections. pmi = Post-Mother-Inoculation

Infants transmit the influenza virus to mother mammary glands

Mammary glands are a significant point of contact and possible pathogenic transmission within the mother-infant dyad [34]. To investigate the susceptibility of mammary glands to influenza infection and the mammary as a point of transmission, we determined virus presence within mammary tissue and virus shed in expressed milk as shown in the experimental design graphic (Fig 5A). All mammary glands were collected from mothers of directly influenza inoculated infants on Day 4 and Day 7 post-infant-inoculation (3 per time point). Live viral load was quantified from each mammary tissue. MDCK titration assay revealed live virus in 7 of the glands (Fig 5B) where some viral loads reached 6 TCID50/g (Log10) or higher. All mothers assessed had at least one gland positive for live influenza virus. Nipples of positive mammary glands also had significant amounts of live influenza virus on Day 4 post-infant-inoculation (3–7 TCID50/g (Log10)) (Fig 5C).

Virus replication and pathology in mammary glands of mothers nursing 2009 H1N1-infected infants.
Fig. 5. Virus replication and pathology in mammary glands of mothers nursing 2009 H1N1-infected infants.
Infant ferrets were intranasally inoculated with A/Cal and housed with mother ferrets for a 7 Day time course where mammary glands, milk, blood, and feces were collected as shown in the schematic (A). Live virus was quantified by MDCK titration of homogenized mammary tissue (B), nipples (C), and expressed milk (D) from nursing-mothers of intranasal inoculated infant ferrets. qRT-PCR was performed on expressed milk for 2009 H1N1 viral RNA (vRNA) (E). Viral presence was also determined by qRT-PCR in infant feces (post-direct-inoculation) (F) and infant, mother, and adult ferret blood (3/4 days post-inoculation) (G). ND = Not Detected. Samples were collected and analyzed from at least 3 independent litter inoculated/infected infants and 3 mothers per time point. Results show the mean or are representative of 3 litters per time point. Mother ferrets have variable numbers of active mammary glands per pregnancy/postpartum.

To determine if influenza virus positive mammary glands were able to shed virus in the milk expressed from the infected mammary gland, we measured both live virus and vRNA in expressed milk from mothers of infected infants. Live virus assessment in milk collected between Day 3 and Day 7 post-infant-inoculation revealed virus presence where some samples contained high virus levels between 6–7 TCID50 (Log10) (Fig 5D). vRNA analysis from milk collected on separate occasions showed vRNA was present in some milk samples as high as ~10,000 copies/5 ng totRNA. Most samples collected had between 10 and 1000 copies (Fig 5E). vRNA and live virus were not detected in milk collected at baseline (Fig 5D and 5E). High levels as well as moderate and low levels of vRNA were detected in infant ferret feces (Fig 5F). Negligible or no amounts of vRNA were found in the peripheral blood of intranasally inoculated infants or their mothers to account for viremia contributing to severe disease or virus shedding from milk (Fig 5G). Control directly inoculated adults were also negative for blood vRNA. This data suggested that mammary glands are able to be harbor live influenza virus and viral shedding can occur through milk expression.

We next visualized the virus in 2009 H1N1 influenza positive mammary glands (H1N1+ MG) to determine virus localization and gland pathology following infection. Histopathology and virus localization in H1N1+ MG revealed destruction of mammary architecture (Fig 6). The acini of control glands had either thick epithelial cell layers indicative of active milk production (green arrows) or acini filled with pink proteinaceous fluid (milk) (blue arrows) (Fig 6). Virus staining was not detected in Control mammaries (top right panel). At Day 4 post-infant-inoculation, the glands of nursing-mothers had retained tissue architecture although leukocyte infiltration (yellow arrows) was identified. Foci of virus staining (light brown in color) was also observed (Day 4 post-infant-inoculation). By Day 7, marked increases in leukocyte infiltration (yellow arrows) in and surrounding the lobules was noted in some mammary glands (Fig 6) where the lobules of these glands had lost typical mammary acini architecture (bottom left panel). Increased viral staining was seen by Day 7 post-infant-inoculation with loss of significant tissue structure (bottom right panel). Viral staining was more pronounced in epithelial cells (black arrows) (semi-quantitative analysis). These data provide evidence that the influenza virus is capable of infecting cells of the mammary gland.

Destruction of acini and accumulation of viral protein in mammary glands of mothers of infected infants.
Fig. 6. Destruction of acini and accumulation of viral protein in mammary glands of mothers of infected infants.
Pathological destruction was determined by H&E (left) and IHC for IAV (right) analysis of paraffin-embedded mammary sections from nursing-mothers of infected infants. Black arrows denote areas of virus expression determined by anti-IAV staining. Yellow arrows denote areas of leukocyte infiltration. Blue arrows show milk protein accumulation. Green arrows indicate active epithelial cell layers. Control = mammary glands from nursing-mothers of mock inoculated infants. Samples were collected and analyzed from at least 3 independent litter inoculated/infected infants and 3 mothers per time point. Results show are representative of 3 litters per time point. Mother ferrets have variable numbers of active mammary glands per pregnancy/postpartum.

Downregulation of milk production gene signaling and increased oncogene pathways in infected mammary glands

To uncover the molecular mechanisms of influenza infection within the mammary glands we performed gene expression analysis on RNA isolated from H1N1+ MGs. Global gene expression analysis by hierarchical clustering using Pearson correlation revealed increased expression of innate immune and cell remodeling genes, as well as downregulation of metabolism and lymphocyte activation genes (Fig 7A).

2009 H1N1 virus positive mammary glands have distinct genetic signatures linked to the regulation of milk production, cancer and immune responses.
Fig. 7. 2009 H1N1 virus positive mammary glands have distinct genetic signatures linked to the regulation of milk production, cancer and immune responses.
A clustergram of the global expression analysis of H1N1+ MGs is shown and the most prominent functional groups are indicated for each cluster (A). Clustergrams of H1N1+ MG gene expression for specific signaling pathways and gene networks were produced (described in methods) (B). Immune Responses were analyzed by comparing the genes expression profiles of 2009 H1N1 infected Adult Ferret Lungs against the H1N1+ MGs (C). Clustergrams for immune response analysis were generated with genes exhibiting statistically significant differential regulation in either ferret mammary glands or lungs. Gene enrichment scores for KEGG-defined signaling cascades among significantly upregulated (red) and downregulated (red) gene subsets at Days 3/4 and Days 6/7 are shown (D). Values above threshold (α = 0.05) indicate statistically significant enrichment among upregulated or downregulated gene subsets at a given time-point. Samples were collected and analyzed from 3 independent litter experiments of inoculated/infected infants and 3 mothers per time point.

Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway analysis showed pronounced alterations in signaling gene expression in H1N1+ MGs (Fig 7B; Ingenuity Pathway Analysis S2 Fig, Gene Enrichment Scores S2 Table). Jak-STAT (Janus Kinase-Signal Transducers and Activators of Transcription) signaling was prominently affected, highlighted by increased STAT3 and involution signaling (STAT3, PIAS4, and SOCS5). Corresponding decreases were seen in STAT5A/B milk production and STAT associated gene networks PRL (Prolactin), STAT5A/B, SOCS1 (Suppressors of Cytokine Signaling 1), JAK3, EPO (Erythropoietin), and EPOR (Erythropoietin Receptor)) [3538]. As well as PRL, other genes involved in milk production [39], LPO (Lactoperoxidase), LPL (Lipoprotein lipase), ATP2B2 (ATPase for Ca2+ transport during milk production), SLC34A2 (protein component of milk), LALBA (alpha-lactalbumin), and CSN2 (β-casein), were also significantly downregulated (Fig 7B).

Cancer Related and Cell Cycle genes including Wnt, p53, and TGFβ signaling pathways, as well as cell attachment (Focal Adhesions and Adherens Junctions) gene networks, were regulated in H1N1+ glands. Significant expression of M2 macrophage genes were found including CD163, CLEC7A (C-type lectin domain family 7, member A), MSR1, CD209, LGMN (Legumain), and MRC1 (Mannose receptor C type 1) transcripts (Fig 7B). MMP1, MMP2, MMP8, MMP11, and MMP14 matrix metalloproteases were also increased along with collagen genes COL5A2, COL3A1, COL1A1, COl1A2, COL4A1, COL6A3, and COL4A6 (Fig 7B and S2 Fig). Upregulation of Integrins (ITGA4, ITGB5, ITGB1, ITGB6) and other genes involved in Focal Adhesions and Adherens Junctions (CAV1 (Calveolin 1), RAP1A, PAK1 (p21 Activated Kinase), ROCK1 (Rho Kinase), VAV1 (guanine nucleotide exchange factor), WASL (Wiskott-Aldrich Syndrome-Like), SPPL1) was also noted (Fig 7B and S2 Fig). Gene networks involved in Cell Cycle and Cell Proliferation/Stress were also prominent. These included MAP Kinase associated protein genes (MAP2K3, MAP2K6, MAPK8, MAPK13, MAPK1, MAP2K1, MAP2K4, JUN, and FOS) and Cyclin regulation genes (CDC16, CD4, CDKN2D, CDKN2D, CDKN1A, CDC26, CDK7, CDC45) (S2 Fig). Many of these genes have known roles in cancer gene networks such as the proto-oncogenes JUN and FOS, RAP1A (RAS-related protein 1A), ITGB5, as well as BRCA2 (Breast cancer 2, early onset) and PCNA (Proliferating cell nuclear antigen) (Fig 7B and S2 Fig). The P53 gene network included both pro- and anti-apoptotic gene upregulation (Bax, CASP9 (Caspase 9), CASP3 (Caspase 3), PTEN (Phosphatase and Tensin homolog), CDK4, and MDM4 (Mouse Double Minute 4)).

Functional annotation analysis by KEGG classification of significantly upregulated or downregulated genes similarly suggested pronounced transcription-level changes in cellular proliferation, remodeling, and metabolic pathways in H1N1+ MG. Genes associated with cell growth, morphology, and catabolism were significantly enriched among upregulated genes while genes implicated in lipid and protein metabolism were dominant among downregulated gene subsets (S2 Table). Seven signaling cascade gene classifications exhibited statistically significant enrichment among upregulated or downregulated genes for at least one time-point (Fig 7D). Among upregulated genes, cell growth (Wnt, TGF-β) and stress response (p53) signaling pathway genes were significantly enriched by Days 6/7 with a trend of increasing enrichment over time. A similar profile was observed for TLR signaling-associated genes. Conversely, genes implicated in Jak-STAT and PPAR signaling were significantly enriched among downregulated genes, with potential implications for milk production (Fig 7D). Microarray gene expression was validated by qRT-PCR for 9 ferret specific primer sets including STAT3, STAT5, FOS, CSN2, and CXCL10 (S3 Fig, Ferret Primer Sequences S3 Table).

To further validate the gene expression results, we analyzed the protein expression of prominent regulators of gene networks discovered in our data analysis. IHC analysis of STAT3 expression in control and H1N1+ MGs (Fig 8, left panels) showed increased STAT3 protein expression in virus positive glands with specific increases within the nucleus and diminished cytoplasmic staining of the mammary gland cells (shown in the inset magnified picture). STAT5 protein was prominent in the control tissue but decreased in the H1N1+ samples (Fig 8, right panels). Together, our gene expression profiling and validation suggests influenza virus infection may regulate milk cessation, breast involution, and oncogenic microenvironment related gene networks.

STAT5 protein is decreased and STAT3 protein is nuclear localized in H1N1+ Mammary Glands.
Fig. 8. STAT5 protein is decreased and STAT3 protein is nuclear localized in H1N1+ Mammary Glands.
STAT5 (right panels) and STAT3 (left panels) protein expression was visualized in Control and H1N1+MG on Day 7 post-infant-inoculation by IHC. IHC analysis of paraffin-embedded mammary sections from nursing-mothers of infected infants stained with STAT5 or STAT3 antibodies were visualized using an Aperio ScanScope XT, Leica Biosystems, Nußloch, Germany for high resolution scans. The inset picture shows a magnification of the scanned image to show cellular detail. Scale bars indicate 100 μm or 10 μm. The images show a representative of mammary glands collected from infant intranasal virus or mock inoculations (three inoculations each).

Since H1N1+ MG had significant differentially regulated gene pathways, we also investigated the expression profiles of Bystander mammary glands to determine if these glands also had evidence of inflammation. We defined Bystander mammary glands to be mammary glands that were negative for virus by qRT-PCR but present on a mother who had H1N1+ MGs. It is not known if Bystander glands were previously virus infected and were able to clear the virus prior to collection and gene profiling. Parallel analyses of Bystander mammary glands (H1N1- at time of collection) partially recapitulated responses detected in H1N1+ MG (S4 Fig; S4 Table). Both H1N1+ and Bystander gland response signatures were characterized by upregulation of proliferation, remodeling, and immune response associated genes (S5 Table). Downregulation of sugar/lipid metabolism genes and STAT5A/B was also a shared feature of both H1N1+ and Bystander glands (S4 Fig; S5 Table). However, Bystander gland responses differed from H1N1+ MG as the PPAR/Hedgehog/Adipocytokine pathway was downregulated and the immune responses were less robust. Catabolism, apoptosis, and TGF-β/p53-associated gene responses characteristic of H1N1+ gland responses were also less pronounced in Bystander glands (S4 Fig).

We next sought to define the immune response regulation within the H1N1+ MGs compared to the canonical gene pathways that have been determined in influenza infected lungs. Clustal analysis of H1N1+ MGs alongside infected lungs revealed the common upregulation of antiviral response pathways but also tissue specific regulation of other immune genes (Fig 7C). Induction of genes typical of the influenza antiviral response [40] such as CXCL10 and CCL2 were seen Day 6/7 post-infant-inoculation in H1N1+ MG (Fig 7C). The immune response also differed in the mammary gland compared to the lung. The response in mammary tissue was characterized by decreased expression of lymphocyte-associated genes such as CD3e, IL2Ra, CD4, AICDA (Activation Induced Cytidine Deaminase) [41]; IL4 and IL1β upregulation; and unchanged IL6 expression (Fig 7C). These results suggest that influenza infected mammary glands are capable of producing an antiviral and immune response that is unique compared to the immune response mounted during infection in the respiratory tract.

Mammary glands are directly susceptible to influenza virus infection leading to tissue pathogenesis and virus transmission to infants

Above we determined that lactating mammary glands are able to host the influenza virus but it was not discerned if the mammary glands were directly susceptible to influenza infection. To determine if mammary glands are able to be infected with the influenza virus infection and act as a vessel of transmission, we inoculated active glands of lactating mother ferrets with Cal/07 (105 EID50) or PBS through the lactiferous ducts (mammary gland inoculation experimental design, Fig 9A). This also allowed us to investigate the direct responses of influenza infection in the mammary gland as well as the role of the mammary gland in virus transmission.

Influenza virus inoculation into active mammary glands of nursing-mother ferrets leads to respiratory infection, severe disease and mortality in infants.
Fig. 9. Influenza virus inoculation into active mammary glands of nursing-mother ferrets leads to respiratory infection, severe disease and mortality in infants.
A schematic depicting the mammary gland inoculation design is shown (A). Temperature (left panel) and weights (right panel) of lactating mother ferrets following 2009 H1N1 (pink lines) or PBS (light grey lines) mammary inoculation (B). Temperature (left panel) and weights (right panel) of infants feeding from lactating mothers with 2009 H1N1 (pink lines) or PBS (light grey lines) inoculated mammary glands (C). Survival of mother and infant ferrets following mammary 2009 H1N1 virus inoculation (D). Live viral load determined from nasal wash in both infant and mothers (E), and live virus shedding from expressed milk (F) following mammary gland 2009 H1N1 inoculation. * Indicates a p-value less than 0.05 determined by ANOVA. Error bars indicate +/- SD. Results are the mean of or represent three independent mammary gland inoculation experiments (3 mammary inoculated mothers, 18 infants) and mock mammary inoculation controls (3 mammary mock inoculated mothers, 21 infants).

Following direct inoculation with Cal/07, mothers and their infants developed significant disease characterized by temperature increases, weight loss, and infant mortality which was not observed in the vehicle inoculation groups (Fig 9). H1N1 mammary inoculated mothers developed a significant fever at 104% of original temperature Day 2 post-mammary inoculation not seen in the mock inoculation control mothers (Fig 9B, left panel). Virus inoculated mothers also lost between 7–10% of their original weight and did not recover by the end of study (Fig 9B, right panel). Infants feeding on virus inoculated mammary glands also had significant weight loss with a 30% survival rate by Day 7 post-mammary-inoculation (Fig 9C, right panel and D). Live virus, average 6 TCID50/ml (Log10), was detected in the NW of infants feeding from virus inoculated glands Day 4 post-mammary-inoculation (Fig 9E). Virus was detected in mother NW after detection in the infants (Day 7 pi). Live virus was present in expressed milk, Day 2 and Day 4 post-mammary-inoculation, between 3 and 13 TCID50/ml (Log10) there by confirming successful inoculation and infection (Fig 9F). As virus was detected in mother NW after in infant NW, these results suggested that infants developed respiratory infection directly from virus shed from the inoculated mammary gland.

Mammary glands were stained with H&E to determine tissue architecture from direct inoculation of 2009 H1N1 and subsequent virus replication. Histopathology showed destruction of acini glandular architecture and absence of milk staining (Fig 10A). Gene expression profiling by qRT-PCR revealed Cal/07 directly inoculated mammary tissues had significant decreases in the milk production genes STAT5A, STAT5B, LPL, and CSN2 (Ferret Primer Sequences S3 Table; Fig 10B). The β-casein protein was decreased in milk samples collected from inoculated tissue when it was able to be collected (S5 Fig). Taken together, direct mammary gland inoculation suggests influenza transmission is possible through breastfeeding and influenza virus infection in mammary tissue leads to pathogenesis and milk cessation.

Influenza virus infection mammary glands causes milk cessation and the destruction of gland architecture.
Fig. 10. Influenza virus infection mammary glands causes milk cessation and the destruction of gland architecture.
High resolution scan of Control and 2009 H1N1 inoculated mammary glands (H&E) (A). qRT-PCR profiles of milk production genes in 2009 H1N1 virus and vehicle inoculated mammary tissue (B). *** Indicates a p-value less than 0.001. Data was collected and analyzed from three independent mammary gland inoculation experiments (3 mammary inoculated mothers, 18 infants) and mock mammary inoculation controls (3 mammary mock inoculated mothers, 21 infants). Results presented show data or are representative of 3 mammary inoculations.

We next sought to determine if human breast cells were also susceptible and permissible to influenza virus infection. To this end we inoculated three cell lines of cultured human epithelial breast cells with Cal/07 strain (2009 H1N1) (in the absence of exogenous proteases) to visualize the virus life-cycle in inoculated cells, assess the viral kinetics, and determine cell viability post-inoculation (Fig 11). “Normal” non-tumorigenic (MCF-10A) and adenocarcinoma (MCF-7 and MCDA-MB-231) human epithelial breast cell lines were used to eliminate single cell type biases. To visualize the virus within the cell and determine virus subcellular localization, inoculated cells were stained for Influenza A Virus (IAV) NP (blue), nucleus (green), and actin filaments (red) (Fig 11A). Positive NP stain was used to determine if viral replication may be occurring within the nucleus. At 24 h post-inoculation influenza NP was detected in the nucleus (white arrows) of all three cell types, MCF-7, MDA-MB-231, and MCF-10A, indicated by co-localization of the nuclear stain (green) with NP staining (blue) (Fig 11A). Furthermore, marked punctate NP accumulation at the plasma membrane was observed in MCF-10A cells (yellow arrows) and to a smaller degree in the other cell types. vRNA was significantly increased in all cells types between 3 and 24 h post-inoculation by ~10 fold (Fig 11B). Cell viability analysis showed significant drops in cell viability of MCF-10A and MDA-MB-231 post-inoculation reaching ~35% viability at the 72 h time point compared to uninoculated cells at the same incubation (Fig 11C). To assess productive infection, live virus was quantified from collected supernatant at each time point. Live viral titers ranged between 3 and 4 TCID50/ml (Log10) for all cell types (Fig 11D). Baseline control (BC) wells had minimal or no detectable live virus. Together, these results suggest that the 2009 H1N1 virus was able to enter “normal” human breast cells leading to virus replication and productive infection.

Human “normal” and adenocarcinoma mammary epithelial cells are susceptible and permissive to 2009 H1N1 infection <i>in vitro</i>.
Fig. 11. Human “normal” and adenocarcinoma mammary epithelial cells are susceptible and permissive to 2009 H1N1 infection in vitro.
Mammary epithelial cells (MCF-7, MDA-MB-231, MCF-10A cells) inoculated at an MOI of 1 with A/Cal (H1N1) were fixed at 24 hours post-inoculation and stained for filamentous actin (red), DNA (green), and influenza A virus NP protein (blue), and imaged by confocal microscopy (A). Mammary epithelial cells (MCF-7, MDA-MB-231, MCF-10A cells) inoculated at an MOI of 1 with A/Cal (H1N1) were collected at 3, 24, 48, and 72 h post-inoculation for quantification of viral RNA segment 7 by qRT-PCR (B), determination of cell viability (C), and live virus quantification in supernatant (D). Confocal pictures are representative of three independent experiments. White arrows indicate nuclear localization of influenza NP protein. Yellow arrows show virus budding along the plasma membrane. BC, Baseline Control.


Here we investigated influenza virus transmission within the mother-infant dyad using a novel ferret model. We found the influenza virus transmitted between nursing-mothers and infants in a bidirectional manner by respiratory and mammary transmission mechanisms. Transmission led to severe lower respiratory disease and mortality. Ferret mammary glands as well as human breast cells were both susceptible to infection and were able to replicate the virus efficiently suggesting mammary glands have the potential to function as a transmission vessel. Substantial changes in gene regulation were observed in H1N1 positive mammary tissue including induction of milk cessation genes and oncogenic pathways accompanying tissue pathogenesis. Influenza has caused high mortality in children (>280/season) and pregnant/postpartum women (~24%) during the influenza season in the United States [8,10] and our study may be used for future investigations of immune responses and therapeutic testing in these populations.

Infants and toddlers are infected with 8 to 10 respiratory viruses (such as RSV) as well as other common viruses (rotavirus, enteroviruses (EV71)) each year [2427,42]. Our findings support investigation into the transmission dynamics of influenza and other childhood viruses during breastfeeding. Since retrograde flux of the mammary glands can allow liquid from infants to enter mammary ducts, viral transmission from the infected infants into the breast is possible via breastfeeding. The susceptibility of mammary glands to common pathogens may have both beneficial and deleterious long-term consequences which should be considered in future studies. As well, since vRNA was found in infant feces as well as in infant respiratory tracts, both respiratory and gastrointestinal introduction of the influenza virus are possible as routes of infection from mother to infant. Our gene expression profiling in virus positive mammary glands indicated induction of oncogenic pathways as well as immune responses [1922]. Infection in mammary tissue may also evoke effective long-term adaptive immune responses. This may be a response conserved through evolution to serve as an advantage for future fecundity of that mother enabling protection by immune memory.

We found live virus was present in milk and within the mammary glands of mothers feeding 2009 H1N1 virus inoculated infants. Since live virus was shed in the milk, this suggested that infection may also be possible by contact with mother’s milk. Although we showed 2009 H1N1 virus presence in the mammary gland by four independent methods, immunohistochemistry, tissue viral load assay, milk viral load assay, and qRT-PCR, the kinetics of the virus expression in these assays were not always correlative. Since the milk vRNA and milk live viral load data were not aliquots of the same sample it is possible the amount of virus shed in milk may not be regular throughout the day or in each infection. RNA extraction from milk samples presented challenges due to the fat content of the milk which were not encountered in live viral load assessment of either milk or mammary gland tissue which may explain the higher live viral loads. As well, milk viral quantifications may differ from that of the mammary gland tissue viral quantification since virus in the milk may be diluted or concentrated dependent on the fullness of the mammary gland at the time of milking. Although these data did not directly correlate, the presence of virus in milk and within the mammary glands was a consistent finding.

To investigate the transmission potential through breastfeeding and the direct role of the mammary gland, we conducted direct virus inoculations to the mammary gland. By directly inoculating the mammary gland, we were able to eliminate the possibility of respiratory transmission in the initial portion of the experiment by isolating the infection within the mammary. Controlling the experiment through other means such as the addition a non-lactating adult to the cage of mother and infants brings ethical considerations as the presence of another adult would put the infant ferrets in danger. In our inoculation experiments, virus began shedding in milk Day 2 post-mammary-inoculation and was present in the infant NW between 2 and 4 days post-mammary-inoculation. Since virus was not detected in mother NW until later in the time course, this data suggested that the infants received the virus from infected mammary glands, not through the mother’s respiration. Virus transmitted from the mammary gland led to severe disease and infant mortality despite the atypical influenza transmission mode. Since infants are susceptible to respiratory tract infection by various microbes present in mammary glands/milk, such as bacteria and yeast [4346], our findings showing respiratory infection from pathogens present in breast milk may have implications into possible sources of bacteria that may participate in influenza-bacterial co-infections in neonates. Moreover, influenza infection in mammary tissue may exacerbate or increase mastitis incidence in mothers and should be investigated in relation to resident and foreign microbial populations. Together, these results give insight into mechanisms which may contribute to influenza severity in infants and nursing-mothers.

The mammary gland is a unique organ which undergoes several structural and molecular transformations throughout the female’s life-cycle, i.e. puberty, pregnancy and postpartum. Pregnancy associated breast cancer (PABC) has been hypothesized to be a consequence of breast remodeling that occurs during pregnancy-lactation cycles and mammary involution [17,18]. We showed increases in oncogene pathways and involution programing in influenza positive glands. Breast involution is characterized by the presence of proteolytic cleavage, apoptosis, and leukocyte recruitment (i.e., macrophages) for secretory alveolar cell removal [17,47]. Our gene expression analysis implicated significant presence of M2 macrophages in influenza infected mammary glands by the upregulation of the M2 specific transcripts CD163, CLEC7A, M5R1, CD209, LGMN, and MRC1. M2 macrophages have a similar phenotype as tumor associated macrophages (TAM), since they regulate MMPs and support a microenvironment favorable for oncogenesis [47]. In agreement with this profile we showed increased MMP1, MMP2, MMP8, MMP11 and MMP14 in the H1N1+ MGs. We also found oncogenic collagen and cell attachment gene signatures upregulated in our data: COL5A2, COL3A1, COL1A1, COL1A2, and COL4A6, Integrins (ITGB6) and cell-matrix interaction proteins (SPP1)[17]. Several of these collagen genes have previously been shown to be associated with both cancer progression and involution in mouse models of mammary involution [17,48,49]. As further validation and discovery, future studies should investigate the full transcriptomics during influenza virus infection in active mammary glands of the ferret to eliminate any biases of the canine microarray. Although no structural or tissue pathological evidence for cancer progression was found in our studies possibly due to the short time frame of the study, clear tissue evidence of milk cessation was seen.

Viruses such as HPV have been shown or speculated to be the etiological agent of specific cancers [50] including breast cancer [19,51]. Breast cancer is the most common cancer affecting women worldwide [52] and viral nucleic acids have been found in breast tumors i.e., bovine leukemia virus (BLV) and mouse mammary tumor virus (MMTV) [19,51]. Viruses may instigate cancer progression through oncogenic viral proteins or by induction of chronic inflammation [19,53,54]. We found induction of genes typical of influenza antiviral responses (CXCL10) [40] as well as cancer associated genes upregulated in H1N1+ MG suggesting mammary glands. As our expression analysis showed the induction of a cancer-promoting microenvironment in mammary glands infected with the influenza virus, it is important to note that viruses that have been found to be directly oncogenic, such as HPV, have infectious cycles differing from that of the influenza virus [23]. Therefore we hypothesize if long-term biological networks are upregulated during influenza infection in breast tissue then those genetic changes would most likely be due to inflammation. The long-term implications of pathogen infection in breast tissue are not known but our data suggests influenza infection leads to short-term pathogenic genetic reprograming within mammary glands.

The CDC recommends continued breastfeeding in the event of infant influenza infection [55]. Although the importance of breastfeeding cannot be overstated [11,12], our findings may impact the management of influenza infection in the mother-infant dyad. Reports have shown most pregnant women with severe influenza infection did not receive the yearly influenza vaccine [10]. Our data reinforces the importance of seasonal influenza vaccination in pregnant and breastfeeding women. Our investigation also suggests that continued breastfeeding during mother or infant influenza infection could lead to breast infection, live virus shedding, and breast pathogenesis. Short-term milk expression by breast pumping with possible pasteurization may be an appropriate strategy for management of influenza infection in the mother-infant dyad. Previously, a guideline has been investigated for the management of influenza transmission in the mother-infant dyad. Since these guidelines had only considered the possibility of respiratory transmission, further investigation and guideline development may be important [56].

Although not much is known regarding viral transmission through breastfeeding, great efforts have been devoted to modeling mother-to-child HIV transmission due to the importance of breastfeeding in HIV high incidence countries [57]. HIV in breast milk exists in both cell-associated (leukocytes) and cell-free forms [34]. Our data suggests that the influenza virus infects glandular epithelial cells whereas HIV primarily targets leukocytes leading to systemic circulation. Our observation here implies novel dynamics of influenza transmission through breastfeeding is a mechanistically different mode of virus transmission in the mother-infant dyad and a formally unidentified system of immune response regulation within the mammary gland for the local production and direct delivery of pathogen specific antibodies. This suggests there is much to be understood regarding the mother-infant relationship and pathogen transmission. Recently, MERS-CoV has been speculated to be transmitted from camels to humans through consumption of camel milk [58]. Together these findings support a hypothesis that respiratory viruses may have the ability to also infect mammary tissue, including human breast cells, possibly due to a shared branched architecture and cellular structure of epithelial cells in lungs and mammary glands.

Materials and Methods

Ethics statement

All animal work was conducted in strict accordance with the Canadian Council of Animal Care (CCAC) guidelines. The protocol license number AUP 1031 was assigned by the Animal Care Committee of the University Health Network (UHN). UHN has certification with the Animals for Research Act including for the Ontario Ministry of Agriculture, Food and Rural Affairs, Permit Number: #0132–01 and #0132–05, and follows NIH guidelines (OLAW #A5408-01). The animal use protocol was approved by the UHN Animal Care Committee (ACC). All efforts were made to minimize animal suffering and infections and sample collections were performed under 5% isoflurane anesthesia.

Influenza virus and animals

The 2009 H1N1 virus strain, A/California/07/2009 (Cal/07), in chicken egg allantoic fluid was provided by the Influenza Reagent Resource, Influenza Division, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, GA, USA. TCID50 and EID50 determinations were done as previously described [59]. All virus work was performed in a BSL-2+ facility as previously described [29]. Four-week-old-male and female ferrets, female Jill ferrets (aged 5 months to 1 year) and male ferrets 8 months old (adult) were bred in an on-site SPF ferret colony (University Health Network, Toronto, ON, Canada). Ferrets were shown to be seronegative by haemagglutination inhibition (HI) assay against currently circulating influenza A and B strains before infection. Infant ferrets were housed in litters with nursing-mother ferrets. Litters were housed according to UHN ferret colony specifications.

Influenza inoculation, mammary gland influenza inoculation, and ferret monitoring

Ferrets were maintained and monitored in litters or as previously described (adults) [29,32]. Briefly, prior to inoculation, 4-week-old nursing ferret litters were randomly selected and housed in appropriate litter boxes contained in bioclean portable laminar-flow clean-room enclosures (Lab Products, Seaford, DE, USA) in the BSL-2+ animal holding area. Baseline body temperature and weight were measured on Day -1 and 0 for each animal. Temperatures were measured by using a subcutaneous implantable temperature transponder (BioMedic Data Systems, Inc., Seaford, DE, USA) for mothers and adults. Infant temperature was measured rectally by DT-610B Single Input K-Type Thermometer (ATP Instrumentation, Leicestershire, United Kingdom).


On the day of inoculation, each ferret was anesthetized and inoculated with 1 ml of Cal/07 inoculum (0.5ml in each nostril) for adults or 200 μl (100 μl in each nostril) for infants both at dose of 105 50% egg infectious dosage (EID50). For each infection experiment three litters at 4-weeks postpartum were randomly chosen for each experimental group (Inoculation or mock control). Each litter included a mother and her infants from a single birthing litter which ranged between 5 and 11 kits depending on the litter. Infection replications were performed simultaneously as well as independently. Data presented represents a minimum of 3 litters with the animal numbers used for data presentation specified in the figure legends where needed.

Mammary gland inoculations

For mammary gland inoculations, mother ferrets of 4 weeks postpartum were anesthetized using isoflurane as previously described for adult ferrets [29]. The mammary glands were warmed with a warm press to express milk. The inoculation site was then cleaned with ethanol. A/Cal H1N1 virus (105 EID50) or PBS control at 125 μl of inoculum was injected by guided ultrasound into the lactiferous duct of the active mammary gland under the supervision of a veterinarian. Half of the active mammary glands were inoculated in a single animal at one time. Mammary glands chosen for inoculation were staggered with mammary glands that were left unaltered to ensure continued feeding by the infant ferrets. Following inoculation, the mother was observed until she was fully awake in the absence of the infant ferrets. The mammary glands were cleaned with ethanol prior to infant ferret reintroduction.

Clinical monitoring

Clinical signs (body temperature, body weight, activity score, symptoms of nasal discharge, sneezing and mammary gland health) were observed daily for 14 days post-infant-inoculation or post-mother-inoculation. Mother ferrets can have a variable number of active mammary glands per pregnancy/postpartum (~5–8). Therefore, a variable number of mammary glands were assessed for viral loads per time point per animal. Mothers and infants were observed twice daily following mammary gland inoculations. Animals were examined at the same time each day for consistency. Nasal discharge and sneezing was observed but confident readings were not able to be recorded due to the small size of the infant ferrets. As well, activity score were not able to be accurately assessed in the infant ferrets due to their low normal activity levels. Mammary glands were observed twice daily following virus inoculation for signs of mastitis (redness, firm tissue and heat) or adverse reaction to injection (hemorrhage, swelling). No signs of adverse reactions or mastitis were noted from inoculation with virus or PBS control.

Sample collection (nasal wash, milk, feces, and tissues)

Nasal washes from the inoculated ferrets were collected on specified days post-inoculation in nasal wash buffer (1% BSA and 100 U/ml penicillin, 100 μg/ml streptomycin in PBS) as previously described [29]. One ml (adults) or 500 μl (infants) of nasal wash buffer was used for each collection. Penicillin and streptomycin were obtained from Invitrogen Canada (Burlington, ON, Canada) and BSA was from Wisent Inc. (Saint-Bruno, QC, Canada). For milk collection, mammary glands were cleaned and a warm press was applied to increase the easy of milking the gland. Milk was collected and pooled from all mammary glands of one mother. Milk for vRNA and live viral load assessments were collected at different milking sessions. Milk was stored in RLT Buffer or directly frozen at -80°C. Tracheas, lungs, mammary glands, and nipples were collected on specified days post-inoculation from the euthanized ferrets. Prior to mammary gland collection, nipples were externally cleaned with ethanol and then the nipples were removed. Internal mammary gland tissue was harvested subsequent to nipple removal. Mother ferrets can have a variable number of active mammary glands per pregnancy/postpartum (~5–8). Therefore, a variable number of mammary glands was assessed for viral loads per time point. As many mammary glands were run as possible to acquire the maximum amount of data. Although the number of glands was variable, the number of mother ferrets was always three ferrets per time point. Feces from infant ferrets were collected at the time of anal temperature collection. Each feces was placed directly in RLT buffer or placed directly at -80°C from the animals’ anus to avoid surface contamination. Samples were stored in -80°C before processing for viral loads or RNA. Samples for RNA were either placed in RNA later (milk and feces) or homogenized in TRIzol (Tissues). Sample aliquots for histopathology were stored in formalin until processing.

Determination of viral load

Viral replication in the upper, middle, and lower respiratory tract and mammary tissues were assessed by endpoint titration of nasal washes or homogenized tissue samples from the inoculated ferrets in MDCK cells (TCID50) using haemagglutination as the readout for positive wells as previously described[29]. Briefly, nasal washes were diluted 1:10 in vDMEM (Dulbecco's modified Eagle's medium containing 1% BSA, 25mM glucose, 1mM sodium pyruvate, 4mM glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 50 μg/ml gentamycin, and 1 μg/ml TPCK-Trypsin) followed by the half log serial dilution in quadruplicate with vDMEM on MDCK cells in 96-well flat-bottom plates (SARSTEDT, Inc., Saint-Leonard, QC, Canada). Tissues were processed similarly and homogenized 1:10 (w/v) in sDMEM (vDMEM excluding 1% BSA) on ice and centrifuged before titration of the homogenates on MDCK cells. Before inoculation, MDCK cells were maintained in the log-phase at low-passage numbers and grown in cDMEM (DMEM containing 10% fetal bovine serum, 25 mM glucose, 1 mM sodium pyruvate, 6 mM glutamine, 1 mM non-essential amino acids, 100 U/ml penicillin, and 100 μg/ml streptomycin). The day before viral sample titration, 2x104 MDCK cells were seeded into each well to reach 95% confluence on the next day. After a two-hour incubation of titrated viral samples with MDCK cells at 37°C, 5% CO2, samples were aspirated and replaced with fresh vDMEM followed by a six-day incubation at 37°C, 5% CO2. On Day 6 post-incubation, supernatants were examined for presence of virus by haemagglutination of 0.5% turkey erythrocytes (Lampire Biological Laboratories, Pipersville, PA, USA). The viral titers were determined as the reciprocal of the dilution resulting in 50% HA positivity in the unit of TCID50/ml represented in log10 base. Viral titers in cell culture supernatants were also determined to investigate capacity of mammary epithelial cells to produce infectious virus in vitro. Cell culture supernatants were loaded directly and serially diluted as described above. Assay upper and lower limits of detection depended on sample availability and/or expected viral titer and varied between experiment types. Lower limits of detection are indicated in all viral load figures by a dashed line. Upper limits of detection were 106.75 TCID50/ml for mammary epithelial cell supernatant assessments, 107.75 and 1013.75 for milk assessments in Fig 5D and Fig 9F, respectively, and 107.25 for all nasal wash and tissue assessments except for S1C Fig (107.75). Cell culture reagents were obtained from Invitrogen Canada or Wisent except for TPCK-Trypsin (Sigma-Aldrich Canada Ltd., Oakville, ON, Canada).

Histopathology and immunohistochemistry

Animals were euthanized on appropriate days and the lung or mammary gland tissues were harvested, perfused and fixed in formalin followed by paraffin embedding and sectioning as described [29]. Tissue slides were then stained with hematoxylin and eosin for histopathology assessment. Nursing-mothers of mock-inoculated 4-week-old infants were used for health and age control. Immunostaining was performed using a polyclonal goat anti-influenza antibody (1:2000) (Abcam (ab20841), Cambridge, United Kingdom). STAT3 protein was detected with a rabbit polyclonal anti-STAT3 (LSBio, Cat # LS-B4693) using CIT6 Antigen Retrieval at 1:300 primary antibody dilution for 1 hour incubation. STAT5 protein was detected with a rabbit polyclonal anti-STAT5 (Abcam, Cat # ab68465) using TE9 Antigen Retrieval at a concentration of 1:100 primary antibody dilution and a 1 hour incubation. High resolution scans were performed using an Aperio ScanScope XT, Leica Biosystems, Nußloch, Germany.

Western blot analysis

Milk was expressed from the mammary glands of lactating mother ferrets. Ten μg of milk was load per lane and proteins were separated by SDS-PAGE and transferred to PVDF membrane. To visualize beta-casein protein, the membrane was blotted with 1:500 rabbit polyclonal anti-bovine beta-casein (Cat# 251309, Abbiotec) and followed with 1:2000 anti-rabbit IgG-HRP (Santa Cruz sc-2030). To ensure equal loading of each sample, a protein estimation was conducted using a Pierce BCA Protein Assay Kit (Life Technologies). Proteins were detected with a chemiluminescence protocol and exposed. Images were exposed to Thermo Scientific CL-XPosure Film (Waltham, MA, USA) and developed using a Konica Minolta Model SRX-101A (Tokyo, Japan) machine.

RNA extraction and quantitative Real-Time PCR (qRT-PCR)

Collected lung and mammary tissue was placed directly in TRIzol reagent (Life Technologies, Burlington, Ontario) for immediate homogenization and subsequently processed according to the manufacturer’s instructions as previously done [32]. Milk RNA was extracted using an RNEasy Kit (Qiagen). Fecal RNA was extract using QIAshredder (Qiagen) before subsequent processing by RNEasy Kit (Qiagen, Hilden, Germany). Total RNA was converted into cDNA using ImProm-II reverse transcription system (Promega Inc., Madison, WI, USA) followed by qRT-PCR. qRT-PCR was performed on the ABI Prism 7900HT system (Applied Biosystems, Foster City, CA, USA). Blood was collected in PAXgene Blood RNA tubes followed by extraction using a PAXgene Blood RNA Kit (PreAnalytiX, Hombrechtikon, Switzerland), per the manufacturer’s instructions. Quadruplicate PCR reactions were run for specified target genes, each containing 4 μl 1.25 ng/μl cDNA, 0.5 μl 4μM forward and reverse primers, and 5 μl SYBR green PCR master mix (Applied Biosystems Inc., Carlsbad, CA, USA). PCR reactions were run at an annealing temperature of 60°C for 35 cycles for blood, tissue, and cell lysates. PCR reactions for milk and fecal RNA were done at 60°C for 40 cycles due to the difficulty of extracting RNA from milk and feces. Applied Biosystems Sequence Detection Systems Version 2.4 software was used for raw data collection (Applied Biosystems, Foster City, CA, USA). Target gene expression levels were normalized to house-keeping gene β-actin, and quantified by the relative standard curve method.

Microarray gene expression analysis

RNA extracted from mammary glands of nursing-mothers (2009 H1N1 and mock inoculated infants) and influenza infected adult lungs were subjected to gene expression analysis by microarray. Mammary glands were determined to be virus infected glands if qRT-PCR found vRNA >10 copies per 5 ng of RNA and histological evidence of virus infection. Mammary glands were determined to be Bystander glands if vRNA was undetectable by qRT-PCR. Total cellular RNA from tissues was collected and purified using TRIzol reagent and methods, as described above. Complementary RNA (cRNA) was generated using 3’ IVT Express Kit (Affymetrix, Santa Clara, CA, USA) and microarray analysis was performed using Affymetrix GeneChip Canine Genome 2.0 Array (Affymetrix, Santa Clara, CA, USA), as previously described [40]. We have previously used and validated canine arrays for the investigation of ferret global gene expression profiling [6064]. We demonstrated high levels of homology (average of 89% identity) between 30 canine and ferret nucleotide sequences [60]. Data sets for H1N1+ mammary glands, bystander mammary glands, and lungs were pre-processed independently with quantile normalization, variance stabilization, and log2 transformation. For genes represented by multiple probes on the array, the probe with highest total signal in H1N1+ mammary gland and lung datasets were selected for analysis. Two parallel analyses were applied A H1N1+ and bystander mammary gland datasets. Global clustering analyses were performed by one-way hierarchical clustering (Pearson’s correlation) of all significantly differentially regulated genes (p-value<0.05 Student’s t-test unpaired, equal variances, fold change ≥ |1.5| fold) and functional annotation of generated clusters. Global pathway gene enrichment analyses were performed by functional annotation of genes exhibiting significant changes in expression at either Days 3/4 or 6/7 in either dataset, using the KEGG Pathway database. DAVID Bioinformatics Resource v6.7, described previously [40] was used for functional annotation and enrichment score profiling. Clustergrams in Fig 7B were manually selected as representative genes for signaling pathways and gene networks prominently represented in global analyses. Genes included in clustergrams were identified as significantly differentially regulated members of related KEGG-defined signaling pathways with the exception of Macrophage and Milk Production clustergrams which were generated by manual selection of representative genes. Full clustergrams of all significantly differentially regulated genes for each KEGG-signaling pathway identified in Fig 7 are included in S2 Fig

Data availability

Accompanying data can be found in the Supplementary Materials. Raw (.CEL files) and normalized microarray data were compiled in accordance with Minimum Information About a Microarray Experiment (MIAME) guidelines and uploaded to the public data repository Gene Expression Omnibus (GEO) for public dissemination ( These datasets can be found under the accession numbers GSE63082 (mammary gland), GSE63083 (lung) and GSE63084 (both) at

In vitro analysis and confocal microscopy

In vitro studies were performed similarly as reported previously [65]. MCF-10A, MFC-7, and MDA-MB-231 cells were purchased from ATCC. The cells were seeded at 50,000 cells/well in 6 well plates for RNA and viral load analysis. Cells were seeded at 75,000 cells per well in Nunc Lab-Tek II Chamber Slide System, 2 well glass slides (Thermo Scientific) for confocal microscopy. Cells were inoculated with A/Cal (H1N1) at a dose of 104 (ELISA assay calculation for MO1 = 1) TCID50 (determined by MDCK titration) per 104 cells (106.5 TCID50 HA assay calculation). For confocal, cells were fixed in 4% PFA in PBS at 24 hours post-inoculation and stained for filamentous actin using Phalloidin (Molecular Probes), DNA using SYTOX green (Molecular Probes), and influenza A virus NP protein using a mouse monoclonal [AA5H] to Influenza A Virus Nucleoprotein (Abcam; ab20343) at 1:100 for 60 min. This was followed by staining with Alexa Fluor 647 Donkey Anti-Mouse secondary (Jackson ImmunoResearch). Prior to staining cells were permeablized using Triton X-100 in PBS. Slides were imaged by confocal microscopy using a Zeiss LSM 710 NLO, using objective C-Apo 63x/1.4 NA (oil). For RNA and viral load, cell lysates and supernatants were collected at 3, 24, 48, and 72 h post-inoculation for RNA extraction and live viral load quantification, respectively. The baseline control was determined by incubating the inoculum in assay wells without cells for 72 h. to assess virus decay and viral attachment to the wells. qRT-PCR and viral load were performed as described in above methods section.

Statistical analyses

Unpaired, unequal variance, two-tail Student’s t-test or one-way ANOVAs were conducted. The Log-rank (Mantel-Cox) Test was used to determine significant differences in animal survival. A p value of ≤ 0.05 was considered statistically significant.

Supporting Information

Attachment 1

Attachment 2

Attachment 3

Attachment 4

Attachment 5

Attachment 6

Attachment 7

Attachment 8

Attachment 9

Attachment 10


1. Hay AJ, Gregory V, Douglas AR, Lin YP (2001) The evolution of human influenza viruses 30. Philos Trans R Soc Lond B Biol Sci 356: 1861–1870. doi: 10.1098/rstb.2001.0999 11779385

2. World Health Organization (WHO) (2015) Influenza (Seasonal).

3. Korteweg C, Gu J (2008) Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172: 1155–1170. S0002-9440(10)61876-7 [pii]; doi: 10.2353/ajpath.2008.070791 18403604

4. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, Campanero-Rhodes MA, Zhang Y, Eickmann M, Kiso M, Hay A, Matrosovich M, Feizi T (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27: 797–799. nbt0909-797 [pii]; doi: 10.1038/nbt0909-797 19741625

5. Doyle TJ, Goodin K, Hamilton JJ (2013) Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) illness in Florida, 2009–2010: a population-based cohort study. PLoS One 8: e79040. doi: 10.1371/journal.pone.0079040; PONE-D-13-14337 [pii]. 24205364

6. Perez-Padilla R, Rosa-Zamboni D, Ponce de LS, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680–689. NEJMoa0904252 [pii]; doi: 10.1056/NEJMoa0904252 19564631

7. Rasmussen SA, Jamieson DJ, Uyeki TM (2012) Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 207: S3–S8. S0002-9378(12)00722-3 [pii]; doi: 10.1016/j.ajog.2012.06.068 22920056

8. Centers for Disease Control and Prevention (CDC) (2014) Seasonal Influenza (Flu): People at High Risk of Developing Flu–Related Complications.

9. Centers for Disease Control and Prevention (2014) CDC 2009–2010 Influenza Season Summary: Influenza-Related Pediatric Mortality.

10. Louie JK, Salibay CJ, Kang M, Glenn-Finer RE, Murray EL, Jamieson DJ (2015) Pregnancy and severe influenza infection in the 2013–2014 influenza season. Obstet Gynecol 125: 184–192. doi: 10.1097/AOG.0000000000000593; 00006250-201501000-00030 [pii]. 25560123

11. World Health Organization (WHO) (2014) Breastfeeding.

12. American Academy of Pediatrics (AAP) (2005) American Academy of Pediatrics: Policy Statement, Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 115: 496–506. 15687461

13. Fernandez L, Langa S, Martin V, Maldonado A, Jimenez E, Martin R, Rodriguez JM (2013) The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res 69: 1–10. S1043-6618(12)00165-X [pii]; doi: 10.1016/j.phrs.2012.09.001 22974824

14. Groer MW, Luciano AA, Dishaw LJ, Ashmeade TL, Miller E, Gilbert JA (2014) Development of the preterm infant gut microbiome: a research priority. Microbiome 2: 38. doi: 10.1186/2049-2618-2-38; 2049-2618-2-38 [pii]. 25332768

15. Khodayar-Pardo P, Mira-Pascual L, Collado MC, Martinez-Costa C (2014) Impact of lactation stage, gestational age and mode of delivery on breast milk microbiota. J Perinatol 34: 599–605. jp201447 [pii]; doi: 10.1038/jp.2014.47 24674981

16. Brandtzaeg P (2010) The mucosal immune system and its integration with the mammary glands. J Pediatr 156: S8–15. S0022-3476(09)01121-4 [pii]; doi: 10.1016/j.jpeds.2009.11.014 20105666

17. Schedin P, O'Brien J, Rudolph M, Stein T, Borges V (2007) Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 12: 71–82. doi: 10.1007/s10911-007-9039-3 17318269

18. Kobayashi S, Sugiura H, Ando Y, Shiraki N, Yanagi T, Yamashita H, Toyama T (2012) Reproductive history and breast cancer risk. Breast Cancer 19: 302–308. doi: 10.1007/s12282-012-0384-8 22711317

19. Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G (2014) Bovine leukemia virus DNA in human breast tissue. Emerg Infect Dis 20: 772–782. doi: 10.3201/eid2005.131298 24750974

20. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91: 1376–1381. 10451442

21. McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK (2001) Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 93: 148–150. 11208885

22. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES (2006) Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 39: 727–731. S0009-9120(06)00091-9 [pii]; doi: 10.1016/j.clinbiochem.2006.03.005 16780823

23. Tommasino M (2014) The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol 26: 13–21. S1044-579X(13)00123-5 [pii]; doi: 10.1016/j.semcancer.2013.11.002 24316445

24. Parashar UD, Nelson EA, Kang G (2013) Diagnosis, management, and prevention of rotavirus gastroenteritis in children. BMJ 347: f7204. doi: 10.1136/bmj.f7204 24379214

25. Boga JA, Melon S, Nicieza I, De D I, Villar M, Parra F, De OM (2004) Etiology of sporadic cases of pediatric acute gastroenteritis in asturias, Spain, and genotyping and characterization of norovirus strains involved. J Clin Microbiol 42: 2668–2674. doi: 10.1128/JCM.42.6.2668–2674.2004; 42/6/2668 [pii]. 15184450

26. Inoue Y, Shimojo N (2013) Epidemiology of virus-induced wheezing/asthma in children. Front Microbiol 4: 391. doi: 10.3389/fmicb.2013.00391 24379810

27. Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ (2012) Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 6: e1737. doi: 10.1371/journal.pntd.0001737; PNTD-D-11-01069 [pii]. 22953003

28. Belser JA, Katz JM, Tumpey TM (2011) The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4: 575–579. dmm.007823 [pii]; doi: 10.1242/dmm.007823 21810904

29. Huang SS, Banner D, Fang Y, Ng DC, Kanagasabai T, Kelvin DJ, Kelvin AA (2011) Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS One 6: e27512. doi: 10.1371/journal.pone.0027512; PONE-D-11-09202 [pii]. 22110664

30. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021–1025. nature08260 [pii]; doi: 10.1038/nature08260 19672242

31. Imai M, Herfst S, Sorrell EM, Schrauwen EJ, Linster M, De GM, Fouchier RA, Kawaoka Y (2013) Transmission of influenza A/H5N1 viruses in mammals. Virus Res 178: 15–20. S0168-1702(13)00239-6 [pii]; doi: 10.1016/j.virusres.2013.07.017 23954580

32. Huang SS, Banner D, Degousee N, Leon AJ, Xu L, Paquette SG, Kanagasabai T, Fang Y, Rubino S, Rubin B, Kelvin DJ, Kelvin AA (2012) Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J Virol 86: 13187–13201. JVI.01456-12 [pii]; doi: 10.1128/JVI.01456-12 23055557

33. Paquette SG, Huang SS, Banner D, Xu L, Leomicronn A, Kelvin AA, Kelvin DJ (2014) Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection. Virology 464–465: 177–183. S0042-6822(14)00319-5 [pii]; doi: 10.1016/j.virol.2014.07.013 25086242

34. Ndirangu J, Viljoen J, Bland RM, Danaviah S, Thorne C, Van de Perre P, Newell ML (2012) Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLoS One 7: e51493. doi: 10.1371/journal.pone.0051493; PONE-D-12-21307 [pii]. 23284701

35. Humphreys RC, Bierie B, Zhao L, Raz R, Levy D, Hennighausen L (2002) Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143: 3641–3650. doi: 10.1210/en.2002-220224 12193580

36. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179–186. 9009201

37. Philp JA, Burdon TG, Watson CJ (1996) Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett 396: 77–80. 0014-5793(96)01069-1 [pii]. 8906870

38. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ (2004) Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92–109. doi: 10.1186/bcr754;bcr754 [pii]. 14979921

39. Lonnerdal B (2014) Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr 99: 712S–717S. ajcn.113.071993 [pii]; doi: 10.3945/ajcn.113.071993 24452231

40. Leon AJ, Banner D, Xu L, Ran L, Peng Z, Yi K, Chen C, Xu F, Huang J, Zhao Z, Lin Z, Huang SH, Fang Y, Kelvin AA, Ross TM, Farooqui A, Kelvin DJ (2013) Sequencing, annotation, and characterization of the influenza ferret infectome. J Virol 87: 1957–1966. JVI.02476-12 [pii]; doi: 10.1128/JVI.02476-12 23236062

41. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK, Staudt LM (2001) Signatures of the immune response. Immunity 15: 375–385. S1074-7613(01)00194-7 [pii]. 11567628

42. Canadian Paediatric Society (2005) Colds in children. Paediatr Child Health 10: 493–485. 19668664

43. Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, Fox LK, Williams JE, McGuire MK, McGuire MA (2011) Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 6: e21313. doi: 10.1371/journal.pone.0021313; PONE-D-11-05310 [pii]. 21695057

44. Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, Scott L, O'Hanlon DM, Burton JP, Francis KP, Tangney M, Reid G (2014) Microbiota of human breast tissue. Appl Environ Microbiol 80: 3007–3014. AEM.00242-14 [pii]; doi: 10.1128/AEM.00242-14 24610844

45. Martin V, Manes-Lazaro R, Rodriguez JM, Maldonado-Barragan A (2011) Streptococcus lactarius sp. nov., isolated from breast milk of healthy women. Int J Syst Evol Microbiol 61: 1048–1052. ijs.0.021642–0 [pii]; doi: 10.1099/ijs.0.021642–0 20511454

46. Panjaitan M, Amir LH, Costa AM, Rudland E, Tabrizi S (2008) Polymerase chain reaction in detection of Candida albicans for confirmation of clinical diagnosis of nipple thrush. Breastfeed Med 3: 185–187. doi: 10.1089/bfm.2008.0106 18778216

47. O'Brien J, Schedin P (2009) Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14: 145–157. doi: 10.1007/s10911-009-9118-8 19350209

48. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA (2004) Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75–R91. doi: 10.1186/bcr753; bcr753 [pii]. 14979920

49. Rudolph MC, McManaman JL, Hunter L, Phang T, Neville MC (2003) Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J Mammary Gland Biol Neoplasia 8: 287–307. 475656 [pii]. 14973374

50. zur HH (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350. doi: 10.1038/nrc798 12044010

51. Naushad W, Bin RT, Gomez MK, Ashiq MT, Younas M, Sadia H (2014) Detection and identification of mouse mammary tumor virus-like DNA sequences in blood and breast tissues of breast cancer patients. Tumour Biol 35: 8077–8086. doi: 10.1007/s13277-014-1972-3 24839004

52. World Health Organization (WHO) (2014) World Health Organization; Breast Cancer: prevention and control.

53. Amirian ES, Adler-Storthz K, Scheurer ME (2013) Associations between human herpesvirus-6, human papillomavirus and cervical cancer. Cancer Lett 336: 18–23. S0304-3835(13)00357-1 [pii]; doi: 10.1016/j.canlet.2013.04.023 23624298

54. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436–444. nature07205 [pii]; doi: 10.1038/nature07205 18650914

55. Centers for Disease Control and Prevention (CDC) (2014) 2009 H1N1 Flu (Swine Flu) and Feeding your Baby: What Parents Should Know. CDC, Centers for Disease Control and Prevention.

56. Cantey JB, Bascik SL, Heyne NG, Gonzalez JR, Jackson GL, Rogers VL, Sheffield JS, Trevino S, Sendelbach D, Wendel GD, Sanchez PJ (2013) Prevention of mother-to-infant transmission of influenza during the postpartum period. Am J Perinatol 30: 233–240. doi: 10.1055/s-0032-1323585 22926635

57. Rollins N, Coovadia HM (2013) Breastfeeding and HIV transmission in the developing world: past, present, future. Curr Opin HIV AIDS 8: 467–473. doi: 10.1097/COH.0b013e3283632ba2 23756997

58. Reusken C, Farag E, Jonges M, Godeke G, El-Sayed A, Pas S, Raj V, Mohran K, Moussa H, Ghobashy H, Alhajri F, Ibrahim A, Bosch B, Pasha S, Al-Romaihi H, Al-Thani M, Al-Marri S, AlHajri M, Haagmans B, Koopmans M (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill 19. 25597544

59. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37: 937–943. 10074505

60. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, Mytle N, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Rowe T, Kelvin DJ (2008) Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol 82: 11308–11317. JVI.00691-08 [pii]; doi: 10.1128/JVI.00691-08 18684821

61. Cameron MJ, Kelvin AA, Leon AJ, Cameron CM, Ran L, Xu L, Chu YK, Danesh A, Fang Y, Li Q, Anderson A, Couch RC, Paquette SG, Fomukong NG, Kistner O, Lauchart M, Rowe T, Harrod KS, Jonsson CB, Kelvin DJ (2012) Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model. PLoS One 7: e45842. doi: 10.1371/journal.pone.0045842; PONE-D-12-09714 [pii]. 23029269

62. Rowe T, Leon AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM (2010) Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 401: 257–265. S0042-6822(10)00129-7 [pii]; doi: 10.1016/j.virol.2010.02.020 20334888

63. Fang Y, Rowe T, Leon AJ, Banner D, Danesh A, Xu L, Ran L, Bosinger SE, Guan Y, Chen H, Cameron CC, Cameron MJ, Kelvin DJ (2010) Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus. J Virol 84: 8369–8388. JVI.02305-09 [pii]; doi: 10.1128/JVI.02305-09 20534862

64. Danesh A, Cameron CM, Leon AJ, Ran L, Xu L, Fang Y, Kelvin AA, Rowe T, Chen H, Guan Y, Jonsson CB, Cameron MJ, Kelvin DJ (2011) Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. Virology 409: 102–112. S0042-6822(10)00638-0 [pii]; doi: 10.1016/j.virol.2010.10.002 21035159

65. Paquette SG, Banner D, Chi le TB, Leomicronn AJ, Xu L, Ran L, Huang SS, Farooqui A, Kelvin DJ, Kelvin AA (2014) Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion. Virology 448: 91–103. S0042-6822(13)00555-2 [pii]; doi: 10.1016/j.virol.2013.09.022 24314640

Hygiena a epidemiologie Infekční lékařství Laboratoř

Článek vyšel v časopise

PLOS Pathogens

2015 Číslo 10

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Diabetická neuropatie a její léčba
nový kurz
Autoři: MUDr. Michal Dubský, Ph.D.

Mnohočetný myelom: Úvodní léčba netransplantovatelných pacientů

Proč v prevenci zubního kazu kartáček nestačí?
Autoři: doc. MUDr. Romana Koberová – Ivančaková, CSc.

Hypersenzitivita dentinu jako příznak poškození tvrdých zubních tkání
Autoři: MUDr. Erika Lenčová, Ph.D.

Cesta pacienta s CHOPN
Autoři: doc. MUDr. Vladimír Koblížek, Ph.D.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se